These findings are supported by other studies for different cancer types, including colorectal cancer [51], cervical cancer [52] and skin cancer [53], where each of them found an increased uptake of functionalised gold nanoparticles in EGFR-expressing cancer cells in in vitro studies. The gene discussed is EGFR; the disease is cervical carcinoma.